MUTATIONS OF THE BCR-ABL- KINASE DOMAIN EXPLAIN THE IMATINIB FAILURE ONLY IN A MINORITY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

被引：0
|
作者：
Jardan, D. [1 ]
Talmaci, R. [1 ]
Coriu, D. [2 ]
Dragomir, M. [2 ]
Ursuleac, I. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Bucharest, Romania
[2] Fundeni Clin Inst, Bucharest, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1333
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [21] ABL KINASE DOMAIN MUTATIONS ARE INFREQUENT IN EARLY-CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
    Soverini, S.
    Gnani, A.
    Colarossi, S.
    Castagnetti, F.
    Palandri, F.
    Abruzzese, E.
    Orlandi, E.
    Breccia, M.
    Specchia, G.
    Gherlinzoni, F.
    Poerio, A.
    Amabile, M.
    Iacobucci, I.
    Rosti, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 43 - 43
  • [22] Analysis of ABL kinase domain mutations as a probable cause of imatinib resistance in Chronic Myeloid Leukemia patients of Kashmir
    Azad, Niyaz A.
    Shah, Zafar A.
    Pandith, Arshad A.
    Rasool, Roohi
    Rasool, Javed A.
    Baba, Shahid M.
    Aziz, Sheikh A.
    Jeelani, Samoon
    META GENE, 2018, 17 : 93 - 98
  • [23] DETECTION OF ABL KINASE DOMAIN POINT MUTATIONS IN 11 CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB TREATMENT
    Bennour, A.
    Beaufils, N.
    Gabert, J.
    Laatiri, M.
    Elloumi, M.
    Meddeb, B.
    Khelif, A.
    Sennana, H.
    Saad, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 532 - 532
  • [24] Examination of point mutations within the ABL kinase domain of Bcr-Abl fusion gene in Chinese patients with chronic myeloid leukemia who develop imatinib resistance
    Yang, Dongguang
    Zhang, Ri
    Gang, Honglin
    Gu, Jian
    Cen, Jian Nong
    BLOOD, 2007, 110 (11) : 214B - 215B
  • [25] Detection of ABL kinase domain mutations in chronic myeloid leukaemia patients resistant to imatinib
    Ormshaw, Elizabeth
    Akki, Susanna
    Mason, Joanne
    Macdonald, Fiona
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S40 - S40
  • [26] Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naive patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India
    Kuila, Nivedita
    Dash, Nilima
    Sahoo, Devi Prasad
    Pattnayak, Naresh Chandra
    Biswas, Ghanashyam
    Chakraborty, Soumen
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 663 - 666
  • [27] BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome
    Elias, Marjanu Hikmah
    Baba, Abdul Aziz
    Azlan, Husin
    Rosline, Hassan
    Sim, Goh Ai
    Padmini, Menon
    Fadilah, S. Abdul Wahid
    Ankathil, Ravindran
    LEUKEMIA RESEARCH, 2014, 38 (04) : 454 - 459
  • [28] Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
    Hasanova, Aypara
    Asadov, Chingiz
    Karimova, Nigar
    Shirinova, Aytan
    Aliyeva, Gunay
    Alimirzoyeva, Zohra
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [29] Clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    HEMATOLOGIE, 2006, 12 (06): : 373 - 374
  • [30] Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
    Press, Richard D.
    Willis, Stephanie G.
    Laudadio, Jennifer
    Mauro, Michael J.
    Deininger, Michael W. N.
    BLOOD, 2009, 114 (13) : 2598 - 2605
12345